Company: VCYT
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001384101-25-000051
Chunk: 122

Company: VERACYTE, INC.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 122
---
 growth in stockholder value relative to a pre-determined index;

(t) return on equity;

(u) return on capital or on invested capital;

(v) cash flow (including free cash flow or operating cash flows) or cash flow margins;

(w) cash conversion cycle;

(x) economic value added;

(y) individual confidential business objectives;

(z) contract awards or backlog;

(aa) overhead or other expense reduction;

(bb) credit rating;

(cc) strategic plan development and implementation;

(dd) succession plan development and implementation;

(ee) talent, retention, and culture;

#### Veracyte2025 Proxy StatementA-17

#### Appendix A
(ff) customer indicators and/or satisfaction;

(gg) new product invention or innovation;

(hh) achievement of target levels of discovery and/or development of products and services, including but not limited to research or regulatory achievements; attainment of research and development milestones;

(ii) third-party coverage and/or reimbursement objectives;

(jj) test volume metrics;

(kk) improvements in productivity;

(ll) bookings;

(mm) attainment of objective operating goals and employee metrics;

(nn) sales;

(oo) expenses;

(pp) balance of cash, cash equivalents, and marketable securities;

(qq) completion of an identified special project;

(rr) completion of a joint venture or other corporate transaction;

(ss) employee satisfaction and/or retention;

(tt) research and development expenses;

(uu) working capital targets and changes in working capital;

(vv) net new annual contract value;

(ww) net expansion rate; and

(xx) any other metric that is capable of measurement as determined by the Committee.

The Committee may provide for one or more equitable adjustments to the Performance Factors to preserve the Committee’s original intent regarding the Performance Factors at the time of the initial award grant, such as but not limited to, adjustments in recognition of unusual or non-recurring items such as acquisition related activities or changes in applicable accounting rules. It is within the sole discretion of the Committee to make or not make any such equitable adjustments.

28.29. “Performance Period” means one or more periods of time, which may be of varying and overlapping durations, as the Committee may select, over which the attainment of one or more Performance Factors will be measured for the purpose of determining a Participant’s right to, and the payment of, a Performance Award.

28.30. “Permitted Transferee” means any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother